Back to Search
Start Over
Positive airway pressure longer than 24 h is associated with histopathological volutrauma in severe COVID-19 pneumonia—an ESGFOR based narrative case-control review
- Source :
- Scientia
- Publication Year :
- 2022
- Publisher :
- AME Publishing Company, 2022.
-
Abstract
- SARS-CoV-2; Post-mortem microbiology; Volutrauma SARS-CoV-2; Microbiología post mortem; Volutrauma SARS-CoV-2; Microbiologia post mortem; Volutrauma Background and Objective: A thorough understanding of the pathogenic mechanisms elicited by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still requires further research. Until recently, only a restricted number of autopsies have been performed, therefore limiting the accurate knowledge of the lung injury associated with SARS-CoV-2. A multidisciplinary European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group of Forensic and Post-mortem Microbiology-ESGFOR team conducted a non-systematic narrative literature review among coronavirus 2019 disease (COVID-19) pneumonia cases assessing the histopathological (HP) effects of positive airways pressure. HP lung features were recorded and compared between mechanically ventilated (>24 hours) and control (ventilation 24 hours as an independent variable associated with DAD (OR =5.40, 95% CI: 1.48–19.62), fibrosis (OR =3.88, 95% CI: 1.25–12.08), vascular damage (OR =5.49, 95% CI: 1.78–16.95) and association of DAD plus fibrosis plus vascular damage (OR =6.99, 95% CI: 2.04–23.97). Conclusions: We identified that patients mechanically ventilated >24 hours had a significantly higher rate of pulmonary injury on histopathology independently of age and gender. Our findings emphasize the importance of maintaining a protective ventilator strategy when subjects with COVID-19 pneumonia undergo intubation.
- Subjects :
- Therapeutics::Airway Management::Respiration, Artificial [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT]
Pneumònia vírica
terapéutica::manejo de la via aérea::respiración artificial [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS]
enfermedades respiratorias::enfermedades pulmonares::neumonía [ENFERMEDADES]
Other subheadings::Other subheadings::/adverse effects [Other subheadings]
virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES]
Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES]
General Medicine
Otros calificadores::Otros calificadores::/efectos adversos [Otros calificadores]
Respiració artificial - Complicacions
Respiratory Tract Diseases::Lung Diseases::Pneumonia [DISEASES]
COVID-19 (Malaltia) - Complicacions
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Scientia
- Accession number :
- edsair.doi.dedup.....f429b9d90e2bdca1385dc0ec2a3d524b